245 related articles for article (PubMed ID: 30653558)
41. Geriatric screening tools predict survival outcomes in older patients with diffuse large B cell lymphoma.
Sakurai M; Karigane D; Kasahara H; Tanigawa T; Ishida A; Murakami H; Kikuchi M; Kohashi S
Ann Hematol; 2019 Mar; 98(3):669-678. PubMed ID: 30443764
[TBL] [Abstract][Full Text] [Related]
42. Development of an oncological-multidimensional prognostic index (Onco-MPI) for mortality prediction in older cancer patients.
Brunello A; Fontana A; Zafferri V; Panza F; Fiduccia P; Basso U; Copetti M; Lonardi S; Roma A; Falci C; Monfardini S; Cella A; Pilotto A; Zagonel V
J Cancer Res Clin Oncol; 2016 May; 142(5):1069-77. PubMed ID: 26758276
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of the G8 and modified-G8 screening tools for multidimensional health problems in older patients with cancer.
Martinez-Tapia C; Paillaud E; Liuu E; Tournigand C; Ibrahim R; Fossey-Diaz V; Culine S; Canoui-Poitrine F; Audureau E;
Eur J Cancer; 2017 Sep; 83():211-219. PubMed ID: 28750273
[TBL] [Abstract][Full Text] [Related]
44. Detection of frailty in elderly cancer patients: Improvement of the G8 screening test.
Petit-Monéger A; Rainfray M; Soubeyran P; Bellera CA; Mathoulin-Pélissier S
J Geriatr Oncol; 2016 Mar; 7(2):99-107. PubMed ID: 26868830
[TBL] [Abstract][Full Text] [Related]
45. Impact of geriatric assessment on the management of older adults with head and neck cancer: A pilot study.
Neve M; Jameson MB; Govender S; Hartopeanu C
J Geriatr Oncol; 2016 Nov; 7(6):457-462. PubMed ID: 27313080
[TBL] [Abstract][Full Text] [Related]
46. Radiotherapy for Muscle-invasive Bladder Cancer in Very Elderly Patients.
Maebayashi T; Ishibashi N; Aizawa T; Sakaguchi M; Sato K; Matsui T; Yamaguchi K; Takahashi S
Anticancer Res; 2016 Sep; 36(9):4763-9. PubMed ID: 27630325
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancer.
Baitar A; Van Fraeyenhove F; Vandebroek A; De Droogh E; Galdermans D; Mebis J; Schrijvers D
J Geriatr Oncol; 2013 Jan; 4(1):32-8. PubMed ID: 24071490
[TBL] [Abstract][Full Text] [Related]
48. The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).
Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
BMC Cancer; 2017 Jun; 17(1):448. PubMed ID: 28659138
[TBL] [Abstract][Full Text] [Related]
49. Predictive Value of Geriatric Oncology Screening and Geriatric Assessment in Older Patients with Solid Cancers: Protocol for a Danish prospective cohort study (PROGNOSIS-G8).
Ditzel HM; Giger AW; Lund CM; Ditzel HJ; Mohammadnejad A; Pfeiffer P; Ryg J; Jørgensen TL; Ewertz M
J Geriatr Oncol; 2021 Nov; 12(8):1270-1276. PubMed ID: 34176752
[TBL] [Abstract][Full Text] [Related]
50. Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy.
Baitar A; Van Fraeyenhove F; Vandebroek A; De Droogh E; Galdermans D; Mebis J; Schrijvers D
J Geriatr Oncol; 2014 Apr; 5(2):179-84. PubMed ID: 24495700
[TBL] [Abstract][Full Text] [Related]
51. Screening for frailty among older patients with cancer that qualify for abdominal surgery.
Kenig J; Zychiewicz B; Olszewska U; Richter P
J Geriatr Oncol; 2015 Jan; 6(1):52-9. PubMed ID: 25277874
[TBL] [Abstract][Full Text] [Related]
52. Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery.
Quinten C; Kenis C; Decoster L; Debruyne PR; De Groof I; Focan C; Cornelis F; Verschaeve V; Bachmann C; Bron D; Luce S; Debugne G; Van den Bulck H; Goeminne JC; Baitar A; Geboers K; Petit B; Langenaeken C; Van Rijswijk R; Specenier P; Jerusalem G; Praet JP; Vandenborre K; Lycke M; Flamaing J; Milisen K; Lobelle JP; Wildiers H
Qual Life Res; 2019 Mar; 28(3):663-676. PubMed ID: 30511255
[TBL] [Abstract][Full Text] [Related]
53. Health related quality of life in older patients with solid tumors and prognostic factors for decline.
Decoster L; Quinten C; Kenis C; Flamaing J; Debruyne PR; De Groof I; Focan C; Cornelis F; Verschaeve V; Bachmann C; Bron D; Luce S; Debugne G; den Bulck ; Goeminne JC; Baitar A; Geboers K; Petit B; Langenaeken C; Van Rijswijk R; Specenier P; Jerusalem G; Praet JP; Vandenborre K; Lobelle JP; Lycke M; Milisen K; Wildiers H
J Geriatr Oncol; 2019 Nov; 10(6):895-903. PubMed ID: 31005649
[TBL] [Abstract][Full Text] [Related]
54. Pretreatment nutritional risk scores and performance status are prognostic factors in esophageal cancer patients treated with definitive chemoradiotherapy.
Song T; Wan Q; Yu W; Li J; Lu S; Xie C; Wang H; Fang M
Oncotarget; 2017 Nov; 8(58):98974-98984. PubMed ID: 29228742
[TBL] [Abstract][Full Text] [Related]
55. Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma?
Gebbia V; Mare M; Cordio S; Valerio MR; Piazza D; Bordonaro R; Firenze A; Giuffrida D
J Geriatr Oncol; 2021 Jan; 12(1):163-167. PubMed ID: 32653216
[TBL] [Abstract][Full Text] [Related]
56. The predictive value of G8 and the Cancer and aging research group chemotherapy toxicity tool in treatment-related toxicity in older Chinese patients with cancer.
Chan WL; Ma T; Cheung KL; Choi H; Wong J; Lam KO; Yuen KK; Luk MY; Kwong D
J Geriatr Oncol; 2021 May; 12(4):557-562. PubMed ID: 33127385
[TBL] [Abstract][Full Text] [Related]
57. Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer.
Arslan D; Tural D; Koca T; Tastekin D; Kaymak Cerkesli A; Basaran H; Gunduz S; Murat Tatli A; Sezgin Goksu S; Uysal M; Kargi A; Kargi B; Koral L; Ibrahim Bassorgun C; Unal D; Mutlu H; Senol Coskun H; Ozdogan M; Bozcuk H
J BUON; 2015; 20(2):573-9. PubMed ID: 26011352
[TBL] [Abstract][Full Text] [Related]
58. Item analysis of G8 screening in uro-oncologic geriatric patients.
Bouzan J; Nellas S; Stoilkov B; Willschrei P; Horstmann M
Int Urol Nephrol; 2023 Jun; 55(6):1441-1446. PubMed ID: 37067702
[TBL] [Abstract][Full Text] [Related]
59. Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with first-line cisplatin-based chemotherapy: a retrospective analysis of single institution.
Inal A; Kaplan MA; Kucukoner M; Karakus A; Isikdogan A
J BUON; 2012; 17(3):533-6. PubMed ID: 23033295
[TBL] [Abstract][Full Text] [Related]
60. Frailty screening for predicting rapid functional decline, rapid progressive disease, and shorter overall survival in older patients with gastrointestinal cancer receiving palliative chemotherapy - a prospective, clinical study.
Jespersen E; Winther SB; Minet LR; Möller S; Pfeiffer P
J Geriatr Oncol; 2021 May; 12(4):578-584. PubMed ID: 33830020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
